Prospect News: News for Teva Pharmaceutical Industries Ltd.

E-mail us: service@prospectnews.com Or call: 212 374 2800

Bank Loans - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products

Add to balance / Manage account

Not logged in

Prospect News home > Main news index > All issuers starting with T > Issuers starting with T, SP only > All stories on Teva Pharmaceutical Industries Ltd. > Stories on Teva Pharmaceutical Industries Ltd., SP only

Search again

Enter part or all of the issuer name:

Market:

All markets No structured products Bank loans Canadian bonds CLOs Convertibles Distressed debt Emerging markets High yield Investment grade Liability management Municipals PIPEs Preferreds Private placements All leveraged markets Structured products

Market: BK = Bank loans, CV = Convertibles, DD = Distressed Debt, EM = Emerging Markets, HY = High Yield, IG = Investment Grade, LM = Liability Management, MU = Municipals, PP = PIPEs, PF = Preferreds, PV = Private Placements, SP = Structured Products
Recent items, highlighted in orange, are $4.00 each. All others are $1.00 each. Headlines in gray are not currently covered by your subscription.

Teva Pharmaceutical Industries Ltd.

1/26/2025	SP	New Issue: JPMorgan sells $6 million trigger absolute return autocallable notes on Teva
10/20/2022	SP	New Issue: UBS prices $503,000 trigger phoenix autocallables linked to Teva
10/20/2022	SP	New Issue: UBS prices $1.28 million trigger phoenix autocallables linked to Teva
10/11/2022	SP	New Issue: UBS prices $503,000 trigger phoenix autocallables linked to Teva
10/11/2022	SP	New Issue: UBS prices $1.28 million trigger phoenix autocallables linked to Teva
9/23/2022	SP	New Issue: UBS prices $2.67 million trigger phoenix autocallables linked to Teva
9/1/2022	SP	New Issue: UBS prices $1.23 million trigger phoenix autocallables linked to Teva
7/6/2022	SP	New Issue: UBS prices $1.32 million trigger phoenix autocallables linked to Teva Pharmaceutical
7/6/2022	SP	New Issue: UBS prices $308,000 trigger phoenix autocallables linked to Teva Pharmaceutical
5/24/2022	SP	New Issue: UBS prices $1.18 million trigger phoenix autocallables linked to Teva
4/21/2022	SP	New Issue: UBS prices $120,000 trigger phoenix autocallables linked to Teva
4/12/2022	SP	New Issue: UBS prices $1 million trigger phoenix autocallables linked to Teva
3/18/2022	SP	New Issue: UBS prices $2.89 million trigger phoenix autocallables linked to Teva
2/18/2022	SP	New Issue: UBS prices $1 million trigger phoenix autocallables linked to Teva
12/7/2021	SP	New Issue: UBS prices $500,000 contingent absolute return autocallables linked to Teva
12/7/2021	SP	New Issue: UBS prices $530,000 contingent absolute return autocallables linked to Teva
12/7/2021	SP	New Issue: UBS prices $150,000 contingent absolute return autocallables linked to Teva
11/3/2021	SP	New Issue: UBS prices $1.57 million contingent absolute return autocallables linked to Teva
6/26/2021	SP	New Issue: UBS prices $157,000 trigger phoenix autocallables linked to Teva
6/26/2021	SP	New Issue: UBS prices $1.63 million trigger phoenix autocallables linked to Teva
4/27/2021	SP	New Issue: UBS prices $100,000 trigger autocallables linked to Teva
3/9/2021	SP	New Issue: UBS prices $2.1 million trigger phoenix autocallables linked to Teva Pharmaceutical
2/17/2021	SPSW	Structured products issuance at $1.29 billion for month as market rallies, volatility high
2/11/2021	SP	New Issue: UBS prices $1 million trigger phoenix autocallables linked to Teva
12/4/2020	SP	New Issue: UBS prices $1 million trigger phoenix autocallables linked to Teva Pharmaceutical
12/3/2020	SP	New Issue: UBS prices $2.02 million trigger phoenix autocallables linked to Teva
9/4/2020	SP	New Issue: UBS prices $1 million trigger phoenix autocallables linked to Teva
8/26/2020	SP	New Issue: UBS prices $1.6 million trigger phoenix autocallable optimization securities linked to Teva Pharmaceutical
6/18/2020	SP	New Issue: UBS prices $545,000 trigger phoenix autocallable optimization securities linked to Teva Pharmaceutical
6/18/2020	SP	New Issue: UBS prices $2.38 million trigger phoenix autocallable optimization securities linked to Teva Pharmaceutical
3/4/2020	SP	New Issue: Morgan Stanley prices $1 million 8.76% fixed-coupon autocallables tied to Teva
12/16/2019	SP	New Issue: UBS prices $1.54 million trigger phoenix autocallable optimization securities linked to Teva Pharmaceutical
11/5/2019	SP	New Issue: UBS prices $99,994 21.17% trigger yield optimization notes linked to Teva Pharmaceutical
10/25/2019	SP	New Issue: UBS prices $749,993 16.54% trigger yield optimization notes linked to Teva Pharmaceutical
6/26/2019	SP	New Issue: UBS sells $500,000 trigger phoenix autocallables on Teva Pharmaceutical
5/30/2019	SP	New Issue: CIBC sells $370,000 Raymond James Healthcare Top Selections notes on 15 stocks
5/30/2019	SP	New Issue: CIBC sells $1.64 million Raymond James Healthcare Top Selections notes on 15 stocks
5/17/2019	SP	New Issue: UBS prices $1 million trigger phoenix autocallables linked to Teva
4/10/2019	SP	New Issue: UBS prices $140,000 airbag yield optimization notes linked to Teva
3/26/2019	SP	New Issue: UBS prices $100,000 trigger phoenix autocallable optimization securities linked to Teva Pharmaceutical
3/22/2019	SP	New Issue: UBS prices $100,000 trigger phoenix autocallables linked to Teva
3/12/2019	SP	BofA to price contingent income autocallables tied to three stocks
2/21/2019	SP	New Issue: UBS prices $106,000 buffered return optimization securities linked to Teva Pharmaceutical
9/11/2018	SP	New Issue: Credit Suisse sells $1 million autocallable reverse convertibles tied to three stocks
8/29/2018	SP	New Issue: UBS prices $654,000 trigger phoenix autocallables linked to Teva
8/29/2018	SP	New Issue: UBS prices $200,000 trigger phoenix autocallables linked to Teva
8/20/2018	SP	New Issue: UBS prices $100,000 trigger phoenix autocallables linked to Teva
7/26/2018	SP	New Issue: UBS prices $425,000 trigger phoenix autocallables linked to Teva
6/26/2018	SP	New Issue: UBS prices $100,000 trigger phoenix autocallables linked to Teva
6/22/2018	SP	New Issue: UBS prices $705,000 trigger phoenix autocallables linked to Teva
5/18/2018	SP	New Issue: UBS prices $100,000 trigger phoenix autocallables linked to Teva
4/27/2018	SP	New Issue: UBS prices $100,000 trigger phoenix autocallables linked to Teva
4/5/2018	SP	New Issue: UBS prices $350,000 trigger phoenix autocallables linked to Teva
3/13/2018	SP	New Issue: UBS prices $200,000 trigger phoenix autocallable optimization securities linked to Teva Pharmaceutical
2/28/2018	SP	New Issue: Barclays prices $15 million airbag autocallable yield notes tied to Teva
2/26/2018	SP	New Issue: UBS prices $150,000 trigger phoenix autocallables linked to Teva
2/23/2018	SP	New Issue: UBS prices $290,000 trigger phoenix autocallables linked to Teva
2/16/2018	SP	New Issue: UBS prices $150,000 trigger autocallables linked to Teva
2/5/2018	SP	New Issue: UBS prices $100,000 trigger phoenix autocallables linked to Teva
1/31/2018	SP	New Issue: UBS prices $250,000 trigger phoenix autocallables linked to Teva
1/26/2018	SP	New Issue: UBS prices $799,981 7.37% trigger yield optimization notes linked to Teva
1/24/2018	SP	New Issue: UBS prices $315,000 trigger autocallables linked to Teva Pharmaceutical
1/18/2018	SP	New Issue: UBS prices $596,000 trigger phoenix autocallables linked to Teva Pharmaceutical
1/18/2018	SP	New Issue: UBS prices $440,000 trigger phoenix autocallables linked to Teva Pharmaceutical
1/18/2018	SP	New Issue: UBS prices $130,000 trigger phoenix autocallables linked to Teva Pharmaceutical
1/18/2018	SP	New Issue: UBS prices $200,000 trigger phoenix autocallables linked to Teva Pharmaceutical
1/17/2018	SP	New Issue: UBS prices $100,000 trigger phoenix autocallables linked to Teva
1/16/2018	SP	New Issue: UBS prices $100,000 trigger phoenix autocallables linked to Teva
1/10/2018	SP	New Issue: UBS prices $100,000 trigger phoenix autocallables on Teva Pharmaceutical
1/10/2018	SP	New Issue: UBS prices $100,000 trigger phoenix autocallables linked to Teva
12/29/2017	SP	New Issue: Credit Suisse prices $1.36 million 12.85% contingent coupon autocalls tied to stocks
12/27/2017	SP	New Issue: UBS prices $145,000 trigger phoenix autocallables linked to Teva
12/18/2017	SP	New Issue: UBS prices $645,000 trigger autocallables linked to Teva Pharmaceutical
12/12/2017	SP	New Issue: Credit Suisse sells $500,000 autocallable yield notes linked to Teva
12/11/2017	SP	New Issue: UBS prices $1.28 million trigger phoenix autocallable optimization securities linked to Teva Pharmaceutical
11/27/2017	SP	New Issue: UBS prices $100,000 trigger phoenix autocallables linked to Teva
11/21/2017	SP	New Issue: UBS prices $100,000 trigger phoenix autocallables linked to Teva
10/18/2017	SP	New Issue: UBS prices $125,000 trigger autocallables linked to Teva Pharmaceutical
10/12/2017	SP	New Issue: UBS prices $160,000 trigger phoenix autocallables linked to Teva
10/12/2017	SP	New Issue: UBS prices $643,000 trigger phoenix autocallables linked to Teva
10/12/2017	SP	New Issue: UBS prices $465,000 trigger phoenix autocallables linked to Teva
9/25/2017	SP	New Issue: UBS prices $100,000 trigger phoenix autocallable optimization securities linked to Teva Pharmaceutical
6/20/2017	SP	New Issue: UBS prices $150,000 trigger phoenix autocallables linked to Teva
5/23/2017	SP	New Issue: JPMorgan prices $9.19 million contingent income autocallables linked to Teva
5/12/2017	SP	JPMorgan to price contingent income autocallables linked to Teva ADS
4/25/2017	SP	New Issue: UBS prices $152,000 trigger phoenix autocallables linked to Teva
3/27/2017	SP	New Issue: UBS prices $100,000 airbag yield optimization notes linked to Teva Pharmaceutical
3/7/2017	SP	New Issue: RBC sells $1.44 million contingent coupon barrier autocallables on Teva
2/21/2017	SP	New Issue: UBS prices $100,000 trigger phoenix autocallable optimization securities linked to Teva Pharmaceutical
1/27/2017	SP	New Issue: UBS prices $430,000 trigger phoenix autocallable optimization securities linked to Teva Pharmaceutical
1/3/2017	SP	New Issue: UBS prices $405,000 trigger phoenix autocallable optimization securities linked to Teva Pharmaceutical
12/30/2016	SP	New Issue: GS Finance prices $5.01 million trigger autocallable contingent yield notes on Teva
12/22/2016	SP	New Issue: UBS prices $100,000 trigger phoenix autocallable linked to Teva
12/21/2016	SP	GS plans trigger autocallable contingent yield notes linked to Teva
12/16/2016	SP	New Issue: UBS prices $550,000 trigger phoenix autocallables linked to Teva
12/14/2016	SP	New Issue: UBS prices $105,000 trigger phoenix autocallables linked to Teva
12/14/2016	SP	New Issue: UBS prices $300,000 trigger phoenix autocallables linked to Teva
12/14/2016	SP	New Issue: UBS prices $213,000 trigger phoenix autocallables linked to Teva
12/14/2016	SP	New Issue: UBS prices $1.2 million trigger phoenix autocallables linked to Teva
12/13/2016	SP	New Issue: UBS prices $500,000 trigger phoenix autocallable optimization securities linked to Teva Pharmaceutical
11/22/2016	SP	New Issue: Morgan Stanley prices $6.24 million trigger participation notes linked to 45 stocks
9/1/2016	SP	New Issue: JPMorgan prices $2.96 million trigger autocallable contingent yield notes tied to Teva
8/24/2016	SP	JPMorgan plans trigger autocallable contingent yield notes linked to Teva
8/23/2016	SP	JPMorgan plans trigger autocallable contingent yield notes tied to Teva
7/12/2016	SP	New Issue: RBC prices $1.9 million of phoenix autocallables linked to Teva Pharmaceutical
5/17/2016	SP	New Issue: JPMorgan prices $676,000 contingent interest autocallables linked to pharma stocks
5/5/2016	SP	JPMorgan plans autocallable contingent interest notes on three stocks
9/9/2014	SP	New Issue: Barclays prices $10.34 million 4.5% Yeelds linked to Teva
3/7/2014	SP	New Issue: Barclays prices $10.02 million 6.18% Yeelds linked to Teva
12/12/2013	SP	New Issue: Barclays prices $10.03 million 4.9% Yeelds tied to Teva Pharmaceutical
4/24/2012	SP	New Issue: Morgan Stanley prices $780,000 trigger phoenix autocallables linked to Teva
4/18/2012	SP	Morgan Stanley plans trigger phoenix autocallables linked to Teva
5/21/2010	SP	New Issue: Barclays prices $1 million 8% reverse convertibles linked to Teva Pharmaceutical
3/10/2010	SP	New Issue: Barclays prices $31.5 million 10% income enhanced reverse exchangeables linked to Teva
10/16/2007	SP	Market Commentary: Svensk, Lehman bring large exchangeable deals; Deutsche plans $250 million Morningstar offering
10/15/2007	CVSP	New Issue: Svensk prices $73.7 million 10% exchange notes linked to Teva Pharmaceuticals
10/11/2007	SP	Svensk to price fixed-rate exchange notes linked to Teva Pharmaceuticals
12/22/2006	SP	New Issue: Barclays sells $2 million 8% reverse convertibles linked to Teva
12/6/2006	SP	Barclays to price 8% reverse convertibles linked to Teva
12/4/2006	SP	Barclays to price 8% reverse convertibles linked to Teva Pharmaceutical

©2025 Prospect News. This page is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies, faxing, photocopying or any other form of reproduction.